Yang Mingfeng, Teplow David B
Department of Neurology, David Geffen School of Medicine, and Molecular Biology Institute and Brain Research Institute, University of California, Los Angeles, Los Angeles, CA 90095, USA.
J Mol Biol. 2008 Dec 12;384(2):450-64. doi: 10.1016/j.jmb.2008.09.039. Epub 2008 Sep 24.
Alloform-specific differences in structural dynamics between amyloid beta-protein (Abeta) 40 and Abeta42 appear to underlie the pathogenesis of Alzheimer's disease. To elucidate these differences, we performed microsecond timescale replica-exchange molecular dynamics simulations to sample the conformational space of the Abeta monomer and constructed its free-energy surface. We find that neither peptide monomer is unstructured, but rather that each may be described as a unique statistical coil in which five relatively independent folding units exist, comprising residues 1-5, 10-13, 17-22, 28-37, and 39-42, which are connected by four turn structures. The free-energy surfaces of both peptides are characterized by two large basins, comprising conformers with either substantial alpha-helix or beta-sheet content. Conformational transitions within and between these basins are rapid. The two additional hydrophobic residues at the Abeta42 C-terminus, Ile41 and Ala42, significantly increase contacts within the C-terminus, and between the C-terminus and the central hydrophobic cluster (Leu17-Ala21). As a result, the beta-structure of Abeta42 is more stable than that of Abeta40, and the conformational equilibrium in Abeta42 shifts towards beta-structure. These results suggest that drugs stabilizing alpha-helical Abeta conformers (or destabilizing the beta-sheet state) would block formation of neurotoxic oligomers. The atomic-resolution conformer structures determined in our simulations may serve as useful targets for this purpose. The conformers also provide starting points for simulations of Abeta oligomerization-a process postulated to be the key pathogenetic event in Alzheimer's disease.
淀粉样β蛋白(Aβ)40和Aβ42之间结构动力学的异构体特异性差异似乎是阿尔茨海默病发病机制的基础。为了阐明这些差异,我们进行了微秒时间尺度的复制交换分子动力学模拟,以对Aβ单体的构象空间进行采样,并构建其自由能表面。我们发现,两种肽单体都不是无结构的,而是可以被描述为一种独特的统计卷曲,其中存在五个相对独立的折叠单元,包括残基1-5、10-13、17-22、28-37和39-42,它们通过四个转角结构相连。两种肽的自由能表面都有两个大的盆地,包含具有大量α螺旋或β折叠含量的构象异构体。这些盆地内部和之间的构象转变很快。Aβ42 C末端的两个额外疏水残基Ile41和Ala42显著增加了C末端内部以及C末端与中央疏水簇(Leu17-Ala21)之间的接触。结果,Aβ42的β结构比Aβ40更稳定,Aβ42的构象平衡向β结构偏移。这些结果表明,稳定α螺旋Aβ构象异构体(或破坏β折叠状态)的药物将阻止神经毒性寡聚体的形成。我们模拟中确定的原子分辨率构象异构体结构可作为为此目的有用的靶点。这些构象异构体也为Aβ寡聚化模拟提供了起点——这一过程被认为是阿尔茨海默病关键的致病事件。